Please join Sidley for a networking event during BIO 2023. Connect with fellow biotech and pharma colleagues and engage in discussion about industry trends and learnings from BIO. RSVP Here […]
Please join Sidley for the Bay Area Lifesciences Roundtable, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. Featured Panels Getting Approved: Creative Approaches to Ensuring Regulatory Success in […]
With deal and investment activity remaining critical for the success of the life sciences and healthcare industry, Sidley is bringing together senior pharma, biotech, healthcare, private equity, and venture capital […]
Join Sidley at our annual Boston Life Sciences Roundtable for an afternoon of engaging discussion addressing cutting-edge trends and hot topics. 1:30 p.m. Registration | 2:00 p.m. Program | 5:00 […]
Join us for an engaging and informative panel discussion on life sciences disputes as part of ICCA 2024 Hong Kong. Our panel comprising Sidley disputes and life sciences specialists as […]
After several years of relatively little enforcement, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several […]
Join Sidley, ISS AG, and Swiss Medtech in Biel for an afternoon of practical tips and interactive discussions on current issues, including: ESG and its development in the EU Seizing […]
Live Oak Workshops, in collaboration with Sidley Austin, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP […]
Deal and investment activity remains critical to the success of life sciences and healthcare innovation. RSVP Here Sidley once again brings together senior pharma, biotech, healthcare, private equity, and venture […]
Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges, and potential strategies for […]
Join us in Basel, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to […]
